Atlas Trials

Refralon Versus Amiodarone for Cardioversion of Paroxysmal Fibrillation and Atrial Flutter

Clinical trial NCT05445297 · COMPLETED

Trial details

NCT number
NCT05445297
Sponsor
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Atrial Fibrillation Paroxysmal
Start date
2022-01-26
Primary completion
2023-06-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.